Nu Skin Enterprises, Inc.
Financials
Valuation Metrics
Nu Skin Enterprises, Inc.'s Market Cap is $226M. At end of 2025 it was $467M. Ranked #2966 of 3,116 in US market (top 95%), #1613 of 1,644 on NYSE (top 98%), #16 of 17 in Household & Personal Products (top 94%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $226M | US#2,966/3,116 Sec#16/17 |
| Revenue | $1.38B | US#1,667/3,116 Sec#16/17 |
| Net Income | $-216M | US—/3,116 Sec—/17 |
| Total Assets | $1.12B | US#2,411/3,116 Sec#16/17 |
| Net Assets | $543M | US#2,165/3,116 Sec#14/17 |
| Employees | 2,800 | US#1,507/3,116 Sec#13/17 |
| Value | ||
| P/B | 0.42x | US#71/3,116 Sec#1/17 |
| P/S | 0.16x | US#81/3,116 Sec#1/17 |
| EV/EBITDA | 7.64x | US#486/3,116 Sec#2/17 |
| FCF Yield | 4.76% | US#1,438/3,116 Sec#11/17 |
| Profitability | ||
| ROE | -39.87% | US#2,622/3,116 Sec#14/17 |
| ROA | -19.29% | US#2,779/3,116 Sec#17/17 |
| Op. Margin | -0.62% | US#2,343/3,116 Sec#16/17 |
| Revenue Growth | -15.44% | US#2,611/3,116 Sec#16/17 |
| Earnings Growth | -314.61% | US#1,957/3,116 Sec#12/17 |
| Financial Health | ||
| Debt Ratio | 106.64% | US#1,150/3,116 Sec#4/17 |
| Total Debt | $264M | US#2,141/3,116 Sec#16/17 |
| FCF | $11M | US#2,224/3,116 Sec#17/17 |
| Cash | $190M | US#1,772/3,116 Sec#13/17 |
| Current Ratio | 1.98x | US#1,246/3,116 Sec#4/17 |
| Net Debt/EBITDA | 1.88x | US#1,291/3,116 Sec#7/17 |
| Dividend | ||
| Div. Yield | 5.15% | US#274/3,116 Sec#4/17 |
| Div. Growth | -0.78% | US—/3,116 Sec—/17 |
| Performance | ||
| 1Y Return | -56.07% | US#2,939/3,116 Sec#16/17 |
| 1M Return | 2.98% | US#1,611/3,116 Sec#13/17 |
| From 52W High | -60.03% | US#2,867/3,116 Sec#16/17 |
| 1Y MDD | -60.75% | US#2,742/3,116 Sec#16/17 |
| Trading | ||
| Volume | 276,935 shares | US#2,670/3,116 Sec#14/17 |
| Trading Value | $1M | US#3,033/3,116 Sec#16/17 |
| Per Share | ||
| EPS | $-4.46 | US—/3,116 Sec—/17 |
| BPS | $11.18 | US#1,758/3,116 Sec#8/17 |
Company Info
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.